The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1692
ISSUE1692
December 25, 2023
Vonoprazan (Voquezna) for Erosive Esophagitis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Vonoprazan (Voquezna) for Erosive Esophagitis
December 25, 2023 (Issue: 1692)
The FDA has approved vonoprazan (Voquezna –
Phathom), a potassium-competitive acid blocker, for
healing and maintenance of healing of all grades of
erosive esophagitis and relief of associated heartburn in adults. Vonoprazan is also available...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.